Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eosinophils | 6 | 2007 | 953 | 0.710 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 4 | 2006 | 691 | 0.550 |
Why?
|
| E-Selectin | 5 | 2013 | 577 | 0.510 |
Why?
|
| Models, Immunological | 1 | 2017 | 512 | 0.470 |
Why?
|
| Fucosyltransferases | 2 | 2013 | 117 | 0.440 |
Why?
|
| Cell Adhesion | 7 | 2021 | 3088 | 0.430 |
Why?
|
| Acetylglucosamine | 3 | 2011 | 189 | 0.420 |
Why?
|
| Galectin 1 | 5 | 2015 | 128 | 0.410 |
Why?
|
| T-Lymphocytes | 5 | 2017 | 10175 | 0.380 |
Why?
|
| Interleukin-9 | 2 | 2021 | 62 | 0.370 |
Why?
|
| Melanoma | 5 | 2024 | 5696 | 0.360 |
Why?
|
| Cell Movement | 9 | 2021 | 5201 | 0.340 |
Why?
|
| Polysaccharides | 2 | 2018 | 1013 | 0.330 |
Why?
|
| Integrin alpha4beta1 | 2 | 2006 | 119 | 0.320 |
Why?
|
| Glycosyltransferases | 1 | 2008 | 115 | 0.300 |
Why?
|
| Selectins | 1 | 2007 | 101 | 0.290 |
Why?
|
| Membrane Glycoproteins | 2 | 2016 | 3688 | 0.280 |
Why?
|
| Melanoma, Experimental | 3 | 2022 | 561 | 0.260 |
Why?
|
| Macrophage-1 Antigen | 1 | 2006 | 285 | 0.250 |
Why?
|
| Prostatic Neoplasms | 4 | 2013 | 11107 | 0.240 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2024 | 110 | 0.230 |
Why?
|
| Bone Neoplasms | 2 | 2013 | 2527 | 0.220 |
Why?
|
| Ligands | 6 | 2015 | 3268 | 0.220 |
Why?
|
| Thrombin | 1 | 2006 | 592 | 0.220 |
Why?
|
| Microcirculation | 1 | 2008 | 1272 | 0.220 |
Why?
|
| Oligosaccharides | 3 | 2011 | 406 | 0.220 |
Why?
|
| Integrins | 1 | 2007 | 834 | 0.210 |
Why?
|
| Amino Sugars | 2 | 2011 | 39 | 0.190 |
Why?
|
| Reactive Oxygen Species | 3 | 2024 | 2137 | 0.190 |
Why?
|
| Immunotherapy | 1 | 2017 | 4642 | 0.190 |
Why?
|
| Asthma | 4 | 2007 | 6234 | 0.180 |
Why?
|
| Keratinocytes | 2 | 2024 | 790 | 0.180 |
Why?
|
| Interferon Type I | 1 | 2024 | 557 | 0.180 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2024 | 619 | 0.170 |
Why?
|
| Inflammation | 3 | 2011 | 10759 | 0.170 |
Why?
|
| Citric Acid Cycle | 1 | 2021 | 231 | 0.170 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2024 | 328 | 0.170 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2022 | 2821 | 0.170 |
Why?
|
| Immunoglobulins | 1 | 2022 | 850 | 0.160 |
Why?
|
| Mucins | 1 | 2022 | 568 | 0.160 |
Why?
|
| Endothelial Cells | 2 | 2009 | 3550 | 0.160 |
Why?
|
| Sialoglycoproteins | 2 | 2009 | 315 | 0.150 |
Why?
|
| Interleukin-17 | 1 | 2024 | 911 | 0.150 |
Why?
|
| Glycolysis | 1 | 2021 | 835 | 0.140 |
Why?
|
| Neoplasm Metastasis | 5 | 2013 | 4910 | 0.140 |
Why?
|
| Tumor Escape | 2 | 2017 | 371 | 0.130 |
Why?
|
| Drug Delivery Systems | 1 | 2007 | 2222 | 0.130 |
Why?
|
| Cell Line, Tumor | 7 | 2024 | 16968 | 0.130 |
Why?
|
| Mice, Inbred C57BL | 9 | 2024 | 22117 | 0.130 |
Why?
|
| Psoriasis | 1 | 2024 | 944 | 0.130 |
Why?
|
| Mice | 14 | 2024 | 81368 | 0.120 |
Why?
|
| Immunoglobulin Fc Fragments | 2 | 2014 | 280 | 0.120 |
Why?
|
| Staphylococcal Protein A | 1 | 2014 | 39 | 0.120 |
Why?
|
| Lectins | 2 | 2018 | 489 | 0.110 |
Why?
|
| Neoplasms | 2 | 2017 | 22131 | 0.110 |
Why?
|
| Animals | 18 | 2024 | 168202 | 0.110 |
Why?
|
| Leukocytes | 3 | 2011 | 2024 | 0.110 |
Why?
|
| P-Selectin | 1 | 2016 | 599 | 0.110 |
Why?
|
| Extracellular Matrix | 1 | 2021 | 1718 | 0.110 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2012 | 1797 | 0.110 |
Why?
|
| Bone Marrow Neoplasms | 2 | 2013 | 101 | 0.110 |
Why?
|
| Chromatography, Affinity | 1 | 2014 | 532 | 0.100 |
Why?
|
| Signal Transduction | 3 | 2024 | 23415 | 0.100 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2012 | 105 | 0.100 |
Why?
|
| Membranes, Artificial | 1 | 2014 | 366 | 0.100 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2011 | 354 | 0.090 |
Why?
|
| Dermatitis, Allergic Contact | 2 | 2012 | 111 | 0.090 |
Why?
|
| Dermatitis, Contact | 1 | 2010 | 133 | 0.090 |
Why?
|
| beta-Galactosidase | 1 | 2011 | 574 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 2 | 2007 | 3793 | 0.080 |
Why?
|
| Interleukin-10 | 2 | 2012 | 1171 | 0.080 |
Why?
|
| Humans | 31 | 2024 | 760740 | 0.080 |
Why?
|
| Leukocyte Rolling | 1 | 2009 | 69 | 0.080 |
Why?
|
| Recombinant Proteins | 3 | 2010 | 6520 | 0.080 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2009 | 335 | 0.080 |
Why?
|
| Acetylation | 1 | 2011 | 1055 | 0.080 |
Why?
|
| Interleukin-5 | 2 | 2006 | 269 | 0.080 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2017 | 2546 | 0.070 |
Why?
|
| Binding Sites | 2 | 2006 | 6051 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2024 | 8542 | 0.070 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2007 | 191 | 0.070 |
Why?
|
| Cell Proliferation | 3 | 2024 | 10429 | 0.070 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2013 | 943 | 0.070 |
Why?
|
| Vitronectin | 1 | 2006 | 40 | 0.070 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2012 | 974 | 0.070 |
Why?
|
| Skin Neoplasms | 2 | 2024 | 5811 | 0.070 |
Why?
|
| Neoplastic Stem Cells | 1 | 2013 | 1350 | 0.060 |
Why?
|
| B-Lymphocytes | 1 | 2018 | 4745 | 0.060 |
Why?
|
| Protein Binding | 2 | 2008 | 9345 | 0.060 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 2409 | 0.060 |
Why?
|
| Hydrolysis | 1 | 2006 | 661 | 0.060 |
Why?
|
| Interferon-Stimulated Gene Factor 3, gamma Subunit | 1 | 2024 | 17 | 0.060 |
Why?
|
| Jurkat Cells | 1 | 2006 | 740 | 0.060 |
Why?
|
| Cell Membrane Structures | 1 | 2004 | 24 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2017 | 14388 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2012 | 11874 | 0.050 |
Why?
|
| CHO Cells | 1 | 2006 | 1387 | 0.050 |
Why?
|
| Janus Kinases | 1 | 2024 | 248 | 0.050 |
Why?
|
| STAT1 Transcription Factor | 1 | 2024 | 340 | 0.050 |
Why?
|
| Cells, Cultured | 4 | 2024 | 18937 | 0.050 |
Why?
|
| Respiratory System | 1 | 2006 | 563 | 0.050 |
Why?
|
| Fibrinogen | 1 | 2006 | 887 | 0.050 |
Why?
|
| Interferon-beta | 1 | 2024 | 345 | 0.050 |
Why?
|
| Cricetinae | 1 | 2006 | 2424 | 0.050 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2006 | 1128 | 0.050 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2015 | 3077 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2017 | 3426 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2006 | 1697 | 0.050 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2006 | 625 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2018 | 11512 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 2021 | 6126 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2012 | 4433 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2018 | 9417 | 0.040 |
Why?
|
| Interferon-alpha | 1 | 2024 | 901 | 0.040 |
Why?
|
| Neoplasm Transplantation | 2 | 2015 | 2010 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2007 | 3965 | 0.040 |
Why?
|
| Bone Marrow | 1 | 2009 | 2909 | 0.040 |
Why?
|
| Peanut Agglutinin | 1 | 2018 | 19 | 0.040 |
Why?
|
| Clone Cells | 1 | 2022 | 1657 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2021 | 495 | 0.040 |
Why?
|
| Sialyltransferases | 1 | 2018 | 83 | 0.040 |
Why?
|
| Interferon-gamma | 2 | 2021 | 3145 | 0.040 |
Why?
|
| Killer Cells, Natural | 1 | 2007 | 2191 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2007 | 1810 | 0.040 |
Why?
|
| Antibodies | 1 | 2006 | 2413 | 0.040 |
Why?
|
| Systems Biology | 1 | 2021 | 481 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2006 | 1878 | 0.030 |
Why?
|
| Cell Survival | 2 | 2021 | 5780 | 0.030 |
Why?
|
| Rhinitis | 1 | 2004 | 747 | 0.030 |
Why?
|
| Germinal Center | 1 | 2018 | 380 | 0.030 |
Why?
|
| Glycosylation | 1 | 2018 | 1098 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2015 | 5034 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2024 | 1896 | 0.030 |
Why?
|
| High-Throughput Screening Assays | 1 | 2021 | 933 | 0.030 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2024 | 2057 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2024 | 4117 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2006 | 13442 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2014 | 3730 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 2015 | 913 | 0.030 |
Why?
|
| Dermis | 1 | 2015 | 202 | 0.030 |
Why?
|
| Skin | 1 | 2007 | 4472 | 0.030 |
Why?
|
| Liver | 1 | 2009 | 7512 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2009 | 4309 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 20988 | 0.030 |
Why?
|
| Male | 5 | 2024 | 360402 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 2022 | 9171 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 1608 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 2467 | 0.020 |
Why?
|
| Apoptosis | 2 | 2021 | 9476 | 0.020 |
Why?
|
| Dimerization | 1 | 2012 | 890 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 2015 | 13635 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2012 | 818 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2013 | 1687 | 0.020 |
Why?
|
| Phenotype | 1 | 2006 | 16572 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 876 | 0.020 |
Why?
|
| Proteomics | 1 | 2021 | 3836 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 6188 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 2189 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2015 | 6223 | 0.020 |
Why?
|
| Cytokines | 2 | 2012 | 7373 | 0.020 |
Why?
|
| Phenanthrolines | 1 | 2004 | 50 | 0.010 |
Why?
|
| Graft Survival | 1 | 2015 | 3814 | 0.010 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2011 | 1779 | 0.010 |
Why?
|
| Disintegrins | 1 | 2004 | 27 | 0.010 |
Why?
|
| Vinculin | 1 | 2004 | 59 | 0.010 |
Why?
|
| Paxillin | 1 | 2004 | 86 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 2007 | 1748 | 0.010 |
Why?
|
| Talin | 1 | 2004 | 47 | 0.010 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2004 | 56 | 0.010 |
Why?
|
| Hematopoiesis | 1 | 2013 | 2049 | 0.010 |
Why?
|
| Gelsolin | 1 | 2004 | 189 | 0.010 |
Why?
|
| Phosphotyrosine | 1 | 2004 | 456 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4569 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2004 | 817 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 2006 | 1156 | 0.010 |
Why?
|
| Immune Tolerance | 1 | 2012 | 2298 | 0.010 |
Why?
|
| Transfection | 1 | 2010 | 5765 | 0.010 |
Why?
|
| Lymphoma | 1 | 2011 | 1899 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2015 | 3233 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 6074 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 9526 | 0.010 |
Why?
|
| Osteoclasts | 1 | 2004 | 711 | 0.010 |
Why?
|
| Female | 3 | 2024 | 392203 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2007 | 4010 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2010 | 5463 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2004 | 1336 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2007 | 2413 | 0.010 |
Why?
|
| Young Adult | 1 | 2024 | 59191 | 0.010 |
Why?
|
| Actins | 1 | 2004 | 2051 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2013 | 6345 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 18220 | 0.010 |
Why?
|
| Adolescent | 1 | 2024 | 88247 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2004 | 2445 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2004 | 4140 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2004 | 4340 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2012 | 12116 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2006 | 12333 | 0.010 |
Why?
|
| Middle Aged | 1 | 2024 | 220603 | 0.010 |
Why?
|
| Macrophages | 1 | 2004 | 5758 | 0.010 |
Why?
|
| Adult | 1 | 2024 | 220995 | 0.010 |
Why?
|
Concepts
(200)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(29)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_